Joyce G. Schwartz,1 William T. Phillips,2and Behrouz Aghebat-Khalry2 Nausea and vomiting have been recurrent problems with the oral glucose tolerance tests (OGTT) used to diagnose diabetes. We believe the nausea is associated with delayed gastric emptying caused by the high osmolarity of the glucose solution. In our pilot study, both the "standard" 100-g glucose OGTT and our new modified (lower osmolar) glucose solution were evaluated. Considerably delayed gastric emptying (along with severe nausea) was consistently noted with the standard OGTT. No nausea and a much more rapid gastric emptying time were recorded when the modified glucose solution was administered.
Nausea and vomiting have been recurrent problems with the oral glucose tolerance tests (OGTT) used to diagnose diabetes. We believe the nausea is associated with delayed gastric emptying caused by the high osmolarity of the glucose solution. In our pilot study, both the "standard" 100-g glucose OGTT and our new modified (lower osmolar) glucose solution were evaluated. Considerably delayed gastric emptying (along with severe nausea) was consistently noted with the standard OGTT. No nausea and a much more rapid gastric emptying time were recorded when the modified glucose solution was administered.
We were able to diagnose diabetes (by using Wilkerson's point system) when our modified OGTT was administered to type 2 diabetics. We plan to develop a more physiological, more reproducible, and better tolerated OGTT to diagnose diabetes more accurately in the general population.
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Glucoseloading tests for the diagnosis of diabetes mellitus were first introduced by Jarney and Isaacson in 1918
(1).
Although wide variations
in results due to age and obesity (2) were reported in the 1920s, John's report of his results of 1100 oral glucose tolerance tests (OGrFs) (7) (8) (9) . The different protocols for OGVFs differ in the amount of glucose administered to the patient, the time at which blood is drawn, and the interpretation of the numerical results. Both the large intraperson and interperson variations during an OG'IT have been emphasized (10, 11). With all of the different variables and disagreements as to its interpretation, the OGT'F, the most popular test for the diagnosis of diabetes or "impaired glucose tolerance," continues to be considered controversial.
However, no one has taken into consideration the osmolarity of the oral glucose solution and the difficulty in gastric emptying caused by its hyperosmolarity.
We believe this delayed gastric emptying not only is responsible for the difliculty in interpretation of the OGTT but also for the nausea and vomiting experienced by most patients who undergo an OGTF. Our pilot study examined the effects on gastric emptying of the standard 100 g of glucose (1.85 mol/L) compared with a new modified 50-g (0.62 mol'L) glucose solution. We also evaluated (a) the reliability with which our new modified OGTI' can be used to diagnose diabetes mellitus; and (b) patients' symptoms (nausea and vomiting) with both the "standard" and our modified OGTF.
Materials and Methods

Subjects.
We evaluated 13 volunteers, using our new modified OGTI'. All patients were between 27 and 42 years old and all had been fasting for longer than 10 h before each test. Four patients were known (type 2) diabetics. Standard OGITs were also administered to a diabetic and a nondiabetic volunteer.
Glucose beverage. We used "Glucose Tolerance Test Beverage," lemon-lime flavor (General Scientific, Richmond, VA 23228) for both the standard and modified OGIT. For the standard test, 100 g of glucose (1.85 mol/L), the contents of the entire bottle, was ingested within 5 mm. For the modified OG'lT, 50 g of glucose (half the bottle's contents) mixed with 450 mL of water (final concentration 0.62 molJL) was ingested within 5 mm. Gastric emptying. We performed gastric-emptying studies with a gamma camera (Scintronix USA Inc., Woburn, MA 01801), using both the modified and routine OGT'Fs, on a diabetic volunteer and a nondiabetic volunteer. These studies were performed at least one week apart to prevent any residual radioactive material from interfering with interpretation of the nuclear scan. About 200 Ci of 99m technetium sulfur colloid (99m Tc-SC; CIS-US, Bedford, MA 01730) was added and stirred into each glucose solution. The 99m Tc-SC was labeled at a local radiopharmacy (Diagnostic Medicine Inc., San Antonio, TX 78229). The volunteers drank all the glucose solution within 5 mm shortly after the 99m Tc-SC was added to the solution.
The volunteers were then placed in a semi-reclining position (45#{176} from horizontal) and the gamma camera was positioned anteriorly. Data were collected continuously and summed at 30-s intervals. Images were acquired until at least half of the glucose solution had emptied from their stomachs.
The Scintronix gamma camera was used with a lowenergy, all-purpose collimator at a 20% window setting centered at 140 keV. It was connected to a computer involve the use of NAD rather than NADP and glucose-6-phosphate dehydrogenase (G-6-PDH) from Leuconostoc mesenteroides rather than yeast. Glucose is phosphorylated to glucose 6-phosphate in the presence of hexokinase, converted to 6-phosphogluconate in the presence of G-6-PDH, and NAD is reduced to NADH, causing a change in absorbance, which is monitored bichromatically at 340/405 nm. The assay temperature is 37#{176}C.
Study Protocol
Gastric-emptying study. After a 10-h fast, one nondiabetic volunteer and one type 2 diabetic were initially given the standard 100 g of glucose in 300 mL of water (one bottle of Glucose Tolerance Test Beverage) to which had been added 200 Ci of 99m Tc-SC. A gastric emptying study with nuclear imaging was then performed, with blood being drawn simultaneously according to the standard OGVF protocol.
One week later our modified OGIT was administered to the same two volunteers while the gastric emptying study was being performed.
Modified
Blood was drawn from the seated volunteers at 0, 30, 60, 90, and 120 mm after they ingested the glucose solution.
Results
Gastric emptying was inhibited in the standard OGTF as compared with the modified OGVF, as seen in Figures 1,2 , and 3. Although gastric emptying was faster for the diabetic volunteer, both the nondiabetic and the diabetic subjects had 50% or more of the standard oral glucose solution in their stomach an hour after the solution was ingested. Much more rapid gastric emptying was observed with the modified solution, allowing glucose to enter the peripheral circulation faster. The half-emptying time was approximately twice as long with the standard OGF (105 mm) as with the modified OGTF (52 mm) in the nondiabetic volunteer.
Utilizing data on half-emptying time from the gastric emptying studies, we calculated that 1.90 kcal were delivered per minute to the duodenum with the standard OGVF, whereas 1.92 kcal were delivered per minute with the modified OGVF; a volume of 1.5 mL was emptied from the stomach per minute in the standard OGIT, 4.5 mL/min with the modified OGTF. The volunteers experienced moderate to severe nausea each time the standard OG'lT was administered as compared with no nausea on any of the 13 times the modified OGTF was administered.
Results of a survey of 10 hospitals in our area revealed that the OG'lT is administered by the hospital phlebotomist or laboratory personnel. After blood and urine sam- Fig.3 . Gastricemptyingin a type2 diabeticvolunteer,showingmore rapidgastric emptying of the modifiedoral glucosesolution pies are obtained, the fasting patient is asked to drink the entire glucose beverage within 10 mm (a few minor variations were described when pregnant patients were being tested). Nausea or vomiting, or both, were reported by the phlebotomistflaboratory personnel in 40% to 80% of the patients who were given a standard OGI'T [all hospitals reported nearly 100% nausea and (or) vomiting in their pregnant patients, the worst symptoms being seen with "cola"-flavored beverages].
Perhaps the most interesting aspect of our study was the fact that, in our nondiabetic volunteers, the serum glucose concentrations consistently peaked at 30 mm with the modified OG'IT (Figure 4) . In our type 2 diabetic volunteers given the modified OGVI', the serum glucose consistently peaked at 1 h or later (Figure 5 ). Although our type 2 diabetic volunteer had a faster gastric emptying time (by 15 mm) than did our nondiabetic volunteer, we noted that his serum glucose peaked 30 mm later than did the nondiabetic's. Using our modified OGTI' and Wilkerson's point system (13), we were able to diagnose diabetes in our diabetic patients.
The interperson variability
seen for the modified OGI'T was greatly improved as compared with other studies in which this aspect of the standard OGTF was examined (13) .
DIscussIon
In its early stages, diabetes mellitus is still extremely difficult to diagnose. Although good methods are now available for measuring plasma insulin (14) and for the quantification of diabetic microangiopathy (15) , from a practical standpoint the clinician must still rely solely upon an increased value for blood glucose to establish the diagnosis of diabetes mellitus. Because fasting hyperglycemia is now generally considered to represent a late manifestation of The serumglucoseclearlypeaksat I h orlater diabetes (9), the average physician will make the diagnosis of diabetes mellitus in a fasting euglycemic patient if he finds that results of the standard glucose tolerance test are abnormal.
One should realize that the term "standard OG'IT' is actually a misnomer, because at least 10 different authors and groups have given suggestions as to how an OGTF should be administered and interpreted (13). It is now believed by many (4-6, 9, 13 ) that most patients diagnosed as having diabetes on the basis of the currently accepted standards for an abnormal OGTT do not have diabetes mellitus and in all probability will never develop the disease.
Our study dealt with two issues. We believed that the reason for the current standard OGIT being unreliable was the variability in gastric emptying caused by the high osmolarity of the glucose solution and that the high incidence of nausea and vomiting associated with the standard OGTF was due to delayed gastric emptying. Nausea and vomiting were completely eliminated when we used our modified OGT'F, and we saw a much more rapid gastric emptying time (by nuclear scan) compared with the standard OGTF.
Brener et al. (16)
, using different glucose concentrations, examined the regulation of gastric emptying of glucose. They found that, soon after the stomach was ifiled, glucose assumed a slow and calorie-constant emptying pattern such that 2.13 kcal of glucose were delivered per minute to the duodenum regardless of the amount or concentration of glucose administered. They described a "closed-loop" system in association with glucose ingestion and stated that a steady-state balance exists between the delivery of glucose to the duodenum and the inhibition of this delivery evoked from the duodenum by the glucose that enters it. We believe this theory explains why so many of the standard OGTTs give erratic results. Once the high osmolar glucose solution of the standard 100-g OGVF reaches the duodenum, gastric emptying is inhibited (thus creating a feeling of nausea). Regardless of the osmolarity of the solution, both the modified and the standard OG'YF will deliver the same number of kilocalories to the duodenum per minute. system for glucose ingestion. Because in our modified OGTT the osmolarity of the solution was a third as great as that used in the standard OGIT, our solution emptied into the duodenum three times faster than the standard OG'lT (4.5 vs 1.5 mL per minute). The modified OGIT is similar to commercial cola beverages in calorie content per milliliter, and we believe it is handled by the body in a much more physiological manner. We therefore believe that it is the osmolarity of the glucose solution that is the controlling factor for gastric emptying and for reliable, reproducible OGITs.
Our nondiabetic volunteers consistently "peaked" their serum glucose concentrations at 30 mm with the modified OGVF, whereas the diabetics consistently peaked at 60 mm with the modified OGVF, even though our diabetic subject showed a more rapid gastric emptying. We believe that we can establish this as a recurrent trend with a larger population. Liddle et a!. (17) described eight normal subjects who were given a 400-mL glucose solution containing 60 g of glucose to which 100 Ci of 99m Tc-SC had been added-a solution similar in osmolarity to our modified OGVF (0.83 mol/L). All of his normal subjects had a maximum value for serum glucose between 30 and 40 mm and a lower glucose value after 60 mm. Yalow et al. (18) found that patients with mild or early non-insulin-dependent diabetes mellitus often display a delay in insulin response followed by late hyperinsulinemia during oral glucose tolerance testing. This fact clearly explains why our nondiabetic patients (as well as Liddle's patients) peaked their serum glucose at 30 mm (with a rapid insulin response) and why it took 60 mm or longer for our type 2 diabetics to attain maximum values for, and then start decreasing, their glucose concentrations (a delay in insulin response). Our modified solution delivers glucose to the peripheral circulation serum at an initial rate greater than or equal to the standard OG'l'T. This should result in similar peak glucose values at 30 mm for both the modified and the standard OGTF. However, the modified solution delivers a more compact bolus of glucose as compared with the standard OGIT, therefore allowing better differentiation between normal and abnormal insulin responses. With the modified OGTF, the tolerance curve for diabetics will have a different shape. We believe that our modified OGIT will allow faster and more accurate diagnosis of diabetes or prediabetes, with fewer side effects. Blood sampling may only be necessary at 0, 30, and 60 mm after the modified glucose solution is ingested, to evaluate when the glucose "peak" occurs and to establish a diagnosis. In normal individuals the peak value is at 30 mm, in diabetics it is at 60 mm or later.
We foresee that eventually the only bottled OGIT beverage will contain 50 g of glucose in 450 mL of flavored water. The new "standard" OGT'F will then be a more nearly accurate, easily tolerated test.
